Remedium Lifecare is charting long-term growth by expanding its global footprint.

The company established REMLIFE GLOBAL PTE.

LTD. in Singapore to streamline international operations and engage global investors.

This strategic move aligns with securing a multi-year USD 21 Million export contract with a leading pharmaceutical distributor, signifying a shift towards a full-spectrum CDMO model.

Strong investor confidence was evident in the recent Rights Issue, with capital earmarked for R&D upgrades, CDMO infrastructure, and international market expansion.

Remedium also enhanced its quality control and partnered for sustainable bioprocesses, solidifying its position as an integrated global pharma partner.